Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ethinyl estradiol + desogestrel is a combination oral contraceptive containing two hormones: ethinyl estradiol (an estrogen) and desogestrel (a progestin). It is used to prevent pregnancy by inhibiting ovulation (the release of an egg from the ovary), thickening cervical mucus to block sperm entry into the uterus, and altering the uterine lining to reduce the likelihood of implantation. This medication does not protect against HIV or other sexually transmitted infections. It is available only with a prescription and comes in various dosing regimens including monophasic (one phase), biphasic (two phases), and triphasic (three phases) packs[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethinyl estradiol + desogestrel.